LENSAR (NASDAQ:LNSR) Issues Quarterly Earnings Results

LENSAR (NASDAQ:LNSRGet Rating) announced its quarterly earnings data on Monday. The company reported ($0.67) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.73) by $0.06, MarketWatch Earnings reports. LENSAR had a negative net margin of 56.88% and a negative return on equity of 32.96%. During the same period in the prior year, the company earned ($0.56) earnings per share.

Shares of NASDAQ:LNSR traded down $0.07 during trading on Tuesday, reaching $7.23. 1,440 shares of the company were exchanged, compared to its average volume of 11,460. The firm has a market capitalization of $79.46 million, a PE ratio of -3.46 and a beta of -0.20. The business’s fifty day simple moving average is $7.11 and its 200-day simple moving average is $6.67. LENSAR has a 12-month low of $5.50 and a 12-month high of $8.98.

A number of hedge funds have recently modified their holdings of LNSR. UBS Group AG purchased a new position in LENSAR during the third quarter valued at approximately $29,000. Geode Capital Management LLC purchased a new position in LENSAR in the third quarter worth $627,000. Finally, Millennium Management LLC purchased a new position in LENSAR in the third quarter worth $853,000. 56.02% of the stock is currently owned by institutional investors.

Separately, Zacks Investment Research raised shares of LENSAR from a “sell” rating to a “hold” rating in a research report on Tuesday, January 11th.

LENSAR Company Profile (Get Rating)

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Featured Stories

Earnings History for LENSAR (NASDAQ:LNSR)

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.